Significance of rare variants in genes involved in the pathogenesis of Lynch syndrome
Open Access
- 26 April 2022
- journal article
- research article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 49 (6) , 1-14
Abstract
The molecular characterization of patients with Lynch syndrome (LS) involves germline testing to detect a deleterious mutation in one of the genes of the mismatch repair (MMR) pathway. To date, however, a large proportion of patients with a clinical suspicion of LS who undergo genetic testing do not show a germline pathogenetic variant in these genes. Germline DNA from 73 patients with a clinical suspicion of LS was examined with next‑generation sequencing methods, using a multigene custom panel designed and standardized by our research group, that targets a set of 15 genes. Deleterious variants were identified in 5.6% of index cases, while unclassified variants were identified in 80.3% of probands. To evaluate the pathogenicity of these uncertain variants, the American College of Medical Genetics and Genomics criteria was used, also considering wherever possible the microsatellite instability (MSI) status detected on tumor tissues as pathogenic criterion. In this manner, 8 of these uncertain significance variants were classified as likely pathogenic variants. Notably, some of these likely pathogenetic variants were also identified in the MLH3 gene that is a gene not routinely analyzed for cases with a clinical suspicion of LS. The present study highlighted the importance of verifying the pathogenicity of the numerous variants of unknown significance identified in patients for whom heredity is already clinically confirmed suggesting the importance of considering the MSI‑H status on the tumor of patients carrying an uncertain variant to evaluate its pathogenicity. Moreover, the present study also suggested analyzing other MMR genes, such as MLH3, in panels used for the molecular screening of LS.Keywords
This publication has 52 references indexed in Scilit:
- Contribution of Large Genomic Rearrangements in Italian Lynch Syndrome Patients: Characterization of a Novel Alu-Mediated DeletionBioMed Research International, 2012
- Predicting the Functional Effect of Amino Acid Substitutions and IndelsPLOS ONE, 2012
- Human Genome Sequencing in Health and DiseaseAnnual Review of Medicine, 2012
- Association of low‐risk MSH3 and MSH2 variant alleles with Lynch syndrome: Probability of synergistic effectsInternational Journal of Cancer, 2010
- Hereditary and Familial Colon CancerGastroenterology, 2010
- Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patientsEuropean Journal of Human Genetics, 2009
- Human Splicing Finder: an online bioinformatics tool to predict splicing signalsNucleic Acids Research, 2009
- The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 MutationsGastroenterology, 2008
- Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6Carcinogenesis, 2006
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991